scholarly journals Establishment of Clinical Prediction Model Based on the Study of Risk Factors of Stroke in Patients With Type 2 Diabetes Mellitus

2020 ◽  
Vol 11 ◽  
Author(s):  
Rong Shi ◽  
Taotao Zhang ◽  
Hui Sun ◽  
Fan Hu
2018 ◽  
Vol 10 ◽  
pp. 100-107 ◽  
Author(s):  
Han Wu ◽  
Shengqi Yang ◽  
Zhangqin Huang ◽  
Jian He ◽  
Xiaoyi Wang

2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Xiaomei Chen ◽  
Qiying Xie ◽  
Xiaoxue Zhang ◽  
Qi Lv ◽  
Xin Liu ◽  
...  

Background. This study is aimed at investigating the systemic risk factors of diabetic retinopathy and further establishing a risk prediction model for DR development in T2DM patients. Methods. This is a retrospective cohort study including 330 type 2 diabetes mellitus (T2DM) patients who were followed up from December 2012 to November 2020. Multivariable cox regression analysis identifying factors associated with the hazard of developing diabetic retinopathy (DR) was used to construct the DR risk prediction model in the form of nomogram. Results. 50.6% of participants (mean age: 58.60 ± 10.55 ) were female, and mean duration of diabetes was 7.09 ± 5.36   years . After multivariate cox regression, the risk factors for developing DR were age (HR 1.068, 95%Cl 1.021-1.118, P = 0.005 ), diabetes duration (HR 1.094, 95%Cl 1.018-1.177, P = 0.015 ), HbA1c (HR 1.411, 95%Cl 1.113-1.788, P = 0.004 ), albuminuria (HR 6.908, 95%Cl 1.794-26.599, P = 0.005 ), and triglyceride (HR 1.554, 95%Cl 1.037-2.330, P = 0.033 ). The AUC values of the nomogram for predicting developing DR at 3-, 4-, and 5-year were 0.854, 0.845, and 0.798. Conclusion. Combining age, diabetes duration, HbA1c, albuminuria, and triglyceride, the nomogram model is effective for early recognition and intervention of individuals at high risk of DR development.


2017 ◽  
pp. 35-44
Author(s):  
Dinh Toan Nguyen

Background: Studies show that diabetes mellitus is the greatest lifestyle risk factor for dementia. Appropriate management and treatment of type 2 diabetes mellitus could prevent the onset and progression of mild cognitive impairment to dementia. MoCA test is high sensitivity with mild dementia but it have not been used and studied widespread in Vietnam. Aim: 1. Using MoCA and MMSE to diagnose dementia in patients with type 2 diabetes mellitus. 2. Assessment of the relationship between dementia and the risk factors. Methods: cross-sectional description in 102 patients with type 2 diabetes mellitus. The Mini-Mental State Examination(MMSE) and the Montreal Cognitive Assessment (MoCA) were used to assess cognitive function. The diagnosis of dementia was made according to Diagnostic and Statistical Manual of Mental Disorders. Results: The average value for MoCA in the group of patients with dementia (15.35 ± 2.69) compared with non-dementia group (20.72 ± 4.53). The sensitivity and specificity of MoCA were 84.8% and 78.3% in identifying individuals with dementia, and MMSE were 78.5% and 82.6%, respectively. Using DSMIV criteria as gold standard we found MoCA and MMSE were more similar for dementia cases (AUC 0.871 and 0.890). The concordance between MoCA and MMSE was moderate (kappa = 0.485). When considering the risk factors, the education,the age, HbA1c, dyslipidemia, Cholesterol total related with dementia in the type 2 diabetes. Conclusion: MoCA scale is a good screening test of dementia in patients with type 2 diabetes mellitus.When compared with the MMSE scale, MoCA scale is more sensitive in detecting dementia. Key words: MoCA, dementia, type 2 diabetes mellitus, risk factors


Sign in / Sign up

Export Citation Format

Share Document